Gene Therapy
Gene therapy companies are part of a scientific vanguard — but must blaze new commercial pathways as well.
On May 17-18, Real Endpoints is bringing together a select group of senior gene therapy executives to discuss, in an informal resort setting and under Chatham House rules, future best practices in the commercialization of this utterly novel class of therapies.
There will be panels – with key participants from senior payers, CMS officials, and providers –but no lectures. There will be plenty of time for conversations, both during the meeting and informally. We will delve into issues such as:
- Launching one-time cures in markets dominated by chronic therapies
- Pricing gene therapies in more prevalent conditions
- The latest innovative contracting approaches
This invite-only event will be one of the most important gene therapy conversations of the year.
Best regards,
Registration
Schedule:
- Wednesday May 17:
- 12 p.m. - 5 p.m.
- 6:30 p.m. cocktail reception and dinner
- Thursday May 18:
- 8 a.m. - 12 p.m., lunch for those that can stay
Location:
The Hermosa Inn in Paradise Valley
Additional housing is available a short distance away from the Hermosa Inn at The Camby. Lodging at both hotels will be booked based on availability. For individuals staying at The Camby, transportation to and from the Hermosa will be provided.
Details:
This is an invite-only meeting and we have reached capacity attendance. Unfortunately, we will not be able to accommodate additional attendees. We will be keeping a waitlist in case spots become available due to last-minute cancellations. If you would like to be added to the waitlist, please email Ellen Licking at elicking@realendpoints.com and complete the registration information. We apologize for any inconvenience this any cause and thank you for your interest in our event.
Agenda:
Host:
Real Endpoints
Contact:
If you have further questions please
email Viviana Ramos:
vramos@realendpoints.com
SPONSORS
